Sharps Technology, Inc. (STSS)
$
5.85
+0.09 (1.54%)
Key metrics
Financial statements
Free cash flow per share
-141.5425
Market cap
5.8 Million
Price to sales ratio
0
Debt to equity
0
Current ratio
1.6132
Income quality
0.7454
Average inventory
2 Million
ROE
-0.9878
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Sharps Technology Inc. is a medical device company dedicated to the research, design, development, manufacturing, distribution, and sale of safety syringe products in the United States. The company reported a net loss of -$9,296,202.00 indicating challenges in its operations, while its EBITDA is -$9,626,710.00 a key indicator of the company's operational profitability. Additionally, the company reported selling, general, and administrative expenses of $7,154,948.00 which reflects its operational overhead costs. Despite these challenges, Sharps Technology achieved a revenue of $0.00 indicating its niche market focus. The gross profit ratio is $0.00 reflecting the efficiency of the company's production and sales operations. Incorporated in 2017, this organization is based in Melville, New York, and offers the Sharps Provensa, an ultra-low waste space syringe aimed at the administration of various vaccines and injectable medications. The stock is affordable at $5.76 suitable for budget-conscious investors. However, it has a low average trading volume of $1,445,417.00 indicating lower market activity. With a market capitalization of $5,961,600.00 the company is classified as a small-cap player. It is a key player in the Medical - Instruments & Supplies industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Healthcare sector, driving innovation and growth. As Sharps Technology navigates its operational hurdles, it remains committed to serving its specialized market while striving for growth within its competitive industry landscape.
Is Sharps Technology, Inc. (STSS) a good investment?
Investing in Sharps Technology, Inc. (STSS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
What is Sharps Technology, Inc. (STSS)'s stock forecast?
Analysts predict Sharps Technology, Inc. stock to fluctuate between $3.30 (low) and $2,224.20 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Sharps Technology, Inc.'s market capitalization?
As of 2025-07-09, Sharps Technology, Inc.'s market cap is $5,961,600, based on 1,019,077 outstanding shares.
How does Sharps Technology, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Sharps Technology, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Sharps Technology, Inc. (STSS) stock?
To buy Sharps Technology, Inc. (STSS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for STSS. Place an order (Market, Limit, etc.).
What is the best time to invest in Sharps Technology, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Sharps Technology, Inc. stock ever split?
Sharps Technology, Inc.'s last stock split was 1:300 on 2025-04-28.
How did Sharps Technology, Inc. perform in the last earnings report?
Revenue: $0 | EPS: -$2,220.05 | Growth: 781.92%.
Where can I find Sharps Technology, Inc.'s investor relations reports?
Visit https://sharpstechnology.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Sharps Technology, Inc.?
You can explore historical data from here
What is the all-time high and low for Sharps Technology, Inc. stock?
All-time high: $79.64 (2022-04-19) | All-time low: $0.01 (2025-04-09).
What are the key trends affecting Sharps Technology, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
marketwatch.com
22 days ago
Shares of Sharps Technology jumped after the company said it has initiated a second shipment from its first commercial order of SoloGard syringes.
globenewswire.com
22 days ago
Second commercial delivery underway as part of multi-year contract with leading U.S. healthcare partner Strategic manufacturing upgrades drive scalability, efficiency, and increases capacity to support production growth NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced an update on the execution of its first shipments under the previously announced $50 million SoloGard sales agreement, alongside a series of advanced manufacturing upgrades. Sharps has initiated the second shipment of its first commercial order of SoloGard syringes under a multi-year supply agreement with a U.S.-based leader in IV flushing solutions.
globenewswire.com
a month ago
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on June 12th, 2025 at 9:30 AM ET. Sharps recently announced that the Company has commenced shipments under three customer orders tied to previously announced purchase agreements.
globenewswire.com
a month ago
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
globenewswire.com
a month ago
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present at the Virtual Investor Summit on June 10, 2025, at 10:00 AM ET. Investors are invited to listen to the presentation and can register here.
benzinga.com
a month ago
Sharps Technology, Inc. STSS stock is trading higher on Wednesday.
globenewswire.com
a month ago
Shipments include initial deliveries of SecureGard™ and SoloGard™ smart safety syringes from its Hungary-based manufacturing facility Deliveries mark the Company's transition to a commercial-stage, revenue-generating company NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced the initiation of shipments for previously announced purchase orders across three customer orders. These shipments mark the Company's first deliveries of its SecureGard™ and SoloGard™ product lines and its transition to generating commercial revenue.
globenewswire.com
2 months ago
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, announces that it has received a notice from Nasdaq confirming that the Company has regained compliance with The Nasdaq's Capital Market's minimum bid price requirement of $1.00 per share and the minimum stockholders' equity requirement of $2.5 million.
globenewswire.com
2 months ago
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025 at 1:00 p.m. ET. Presentation Details: Presenter: Robert Hayes, CEO Date: May 22, 2025 Time: 1:00 p.m.
globenewswire.com
4 months ago
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: STSS) (the “Company” or “Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company's proposal before the shareholder meeting, which is scheduled to be held on March 28, 2025, at 10:00 a.m. Eastern Time.
See all news
